Sign up to save your podcasts
Or
Share Future MDMA Treatment Following FDA's Rejection
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Future MDMA Treatment Following FDA's Rejection
The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment.
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By Cato Institute
4.5
951951 ratings
The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment.
Hosted on Acast. See acast.com/privacy for more information.
More shows like Cato Daily Podcast
View all
Cato Event Podcast
120 Listeners
EconTalk
4,232 Listeners
City Journal Audio
594 Listeners
The Glenn Show
2,255 Listeners
Law Talk With Epstein, Yoo & Cooke
682 Listeners
WSJ Opinion: Potomac Watch
2,794 Listeners
Conversations with Tyler
2,402 Listeners
Cato Audio
29 Listeners
The Fifth Column
2,817 Listeners
The Reason Roundtable
1,493 Listeners
Power Problems
91 Listeners
Uncommon Knowledge
1,970 Listeners
The Political Orphanage
965 Listeners
The Reason Interview With Nick Gillespie
731 Listeners
The Soho Forum Debates
195 Listeners
GoodFellows: Conversations from the Hoover Institution
687 Listeners
WSJ Opinion: Free Expression
576 Listeners
Just Asking Questions
91 Listeners